+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hyperthermia Treatment for Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 121 Pages
  • November 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5910757
The global fight against cancer has taken a significant leap forward with the prominence of hyperthermia treatment. A recent report sheds light on the state of the global hyperthermia treatment for cancer market, highlighting key product types, market drivers, challenges, and emerging opportunities in this critical healthcare sector.

Microwave Hyperthermia Device Dominates In terms of revenue, the microwave hyperthermia device segment has emerged as the dominant product type in the global hyperthermia treatment for cancer market. This segment is poised to further gain traction during the forecast period, thanks to its unique ability to efficiently transmit energy from antennas to cancer cells without becoming hindered by fat layers.

Rising Cancer Incidence Fuels Growth Cancer is on the rise worldwide, with the World Health Organization projecting approximately 13.1 million cancer-related deaths by 2030. The data from WHO also indicates a 75% increase in global cancer prevalence from 2008 to 2030. This escalating cancer incidence is driving an upsurge in the number of patients seeking cancer therapies, subsequently boosting the demand for hyperthermia treatment.

Awareness of Therapeutic Benefits Growing awareness of the therapeutic benefits of hyperthermia for various malignant diseases is contributing to the revenue growth of the global hyperthermia devices market. Experts in the field are educating patients about hyperthermia's potential to destroy tumor cells and enhance drug absorption when used in conjunction with chemotherapy. Clinical trials combining hyperthermia with radiation therapy have shown superior efficacy compared to standalone radiation therapy, further emphasizing the advantages of hyperthermia treatment.

Cost Challenges Despite its effectiveness, the high cost of hyperthermia treatment compared to other cancer procedures is a significant impediment to market growth. In the United States, the average charge for hyperthermia treatment for each cancer type is approximately US$ 50,000. Given that hyperthermia treatment often complements radiation or chemotherapy, the overall cost can be prohibitive for many patients.

Untapped Opportunities in Developing Economies Countries like China and India, with their large populations and high cancer incidence rates, present untapped opportunities for hyperthermia treatment. Although the number of facilities and experienced practitioners for cancer treatment in these countries is currently limited, the growing incidence of cancer is driving the expansion of healthcare infrastructure. This development creates a promising market for hyperthermia device manufacturers to introduce cost-effective and accessible products tailored to the needs of emerging economies.

Market Taxonomy

By Device Type

  • Microwave Hyperthermia Device
  • Ultrasound Hyperthermia Device
  • Infrared Hyperthermia Device
  • Short-wave Hyperthermia Device

By End User

  • Hospitals
  • Clinics
  • Research Institutes
  • Cancer Centers
  • Others

By Application

  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Leukemia
  • Head and Neck Tumors
  • Prostate Cancer
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Hyperthermia Treatment for Cancer Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2018 - 2023
3.1. Global Hyperthermia Treatment for Cancer Market Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2018 - 2023
4.1. Global Average Price Analysis, by Device Type/ Application, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Breast Tissue Markers Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031
5.1. Global Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Microwave Hyperthermia Device
5.1.1.2. Ultrasound Hyperthermia Device
5.1.1.3. Infrared Hyperthermia Device
5.1.1.4. Short-wave Hyperthermia Device
5.2. Global Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Breast Cancer
5.2.1.2. Liver Cancer
5.2.1.3. Soft Tissue Sarcoma
5.2.1.4. Leukemia
5.2.1.5. Head and Neck Tumors
5.2.1.6. Prostate Cancer
5.2.1.7. Others
5.3. Global Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Clinics
5.3.1.3. Research Institutes
5.3.1.4. Cancer Centres
5.3.1.5. Others
5.4. Global Hyperthermia Treatment for Cancer Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa
6. North America Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031
6.1. North America Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Microwave Hyperthermia Device
6.1.1.2. Ultrasound Hyperthermia Device
6.1.1.3. Infrared Hyperthermia Device
6.1.1.4. Short-wave Hyperthermia Device
6.2. North America Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Breast Cancer
6.2.1.2. Liver Cancer
6.2.1.3. Soft Tissue Sarcoma
6.2.1.4. Leukemia
6.2.1.5. Head and Neck Tumors
6.2.1.6. Prostate Cancer
6.2.1.7. Others
6.3. North America Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Clinics
6.3.1.3. Research Institutes
6.3.1.4. Cancer Centres
6.3.1.5. Others
6.4. North America Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. U.S. Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.2. U.S. Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.3. U.S. Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.4. Canada Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.5. Canada Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.6. Canada Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031
7.1. Europe Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Microwave Hyperthermia Device
7.1.1.2. Ultrasound Hyperthermia Device
7.1.1.3. Infrared Hyperthermia Device
7.1.1.4. Short-wave Hyperthermia Device
7.2. Europe Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Breast Cancer
7.2.1.2. Liver Cancer
7.2.1.3. Soft Tissue Sarcoma
7.2.1.4. Leukemia
7.2.1.5. Head and Neck Tumors
7.2.1.6. Prostate Cancer
7.2.1.7. Others
7.3. Europe Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Clinics
7.3.1.3. Research Institutes
7.3.1.4. Cancer Centres
7.3.1.5. Others
7.4. Europe Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Germany Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.2. Germany Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.3. Germany Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.4. U.K. Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.5. U.K. Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.6. U.K. Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.7. France Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.8. France Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.9. France Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.10. Italy Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.11. Italy Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.12. Italy Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.13. Turkey Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.14. Turkey Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.15. Turkey Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.16. Russia Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.17. Russia Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.18. Russia Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.19. Rest of Europe Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.20. Rest of Europe Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.21. Rest of Europe Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031
8.1. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Microwave Hyperthermia Device
8.1.1.2. Ultrasound Hyperthermia Device
8.1.1.3. Infrared Hyperthermia Device
8.1.1.4. Short-wave Hyperthermia Device
8.2. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Breast Cancer
8.2.1.2. Liver Cancer
8.2.1.3. Soft Tissue Sarcoma
8.2.1.4. Leukemia
8.2.1.5. Head and Neck Tumors
8.2.1.6. Prostate Cancer
8.2.1.7. Others
8.3. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Clinics
8.3.1.3. Research Institutes
8.3.1.4. Cancer Centres
8.3.1.5. Others
8.4. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. China Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.2. China Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.3. China Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.4. Japan Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.5. Japan Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.6. Japan Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.7. South Korea Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.8. South Korea Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.9. South Korea Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.10. India Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.11. India Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.12. India Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.13. Southeast Asia Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.14. Southeast Asia Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.15. Southeast Asia Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.16. Rest of Asia Pacific Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.17. Rest of Asia Pacific Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.18. Rest of Asia Pacific Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031
9.1. Latin America Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Microwave Hyperthermia Device
9.1.1.2. Ultrasound Hyperthermia Device
9.1.1.3. Infrared Hyperthermia Device
9.1.1.4. Short-wave Hyperthermia Device
9.2. Latin America Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.2.1.1. Breast Cancer
9.2.1.2. Liver Cancer
9.2.1.3. Soft Tissue Sarcoma
9.2.1.4. Leukemia
9.2.1.5. Head and Neck Tumors
9.2.1.6. Prostate Cancer
9.2.1.7. Others
9.3. Latin America Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Hospitals
9.3.1.2. Clinics
9.3.1.3. Research Institutes
9.3.1.4. Cancer Centres
9.3.1.5. Others
9.4. Latin America Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Brazil Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.2. Brazil Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.3. Brazil Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.4. Mexico Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.5. Mexico Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.6. Mexico Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.7. Argentina Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.8. Argentina Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.9. Argentina Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.10. Rest of Latin America Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.11. Rest of Latin America Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.12. Rest of Latin America Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031
10.1. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Microwave Hyperthermia Device
10.1.1.2. Ultrasound Hyperthermia Device
10.1.1.3. Infrared Hyperthermia Device
10.1.1.4. Short-wave Hyperthermia Device
10.2. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. Breast Cancer
10.2.1.2. Liver Cancer
10.2.1.3. Soft Tissue Sarcoma
10.2.1.4. Leukemia
10.2.1.5. Head and Neck Tumors
10.2.1.6. Prostate Cancer
10.2.1.7. Others
10.3. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Hospitals
10.3.1.2. Clinics
10.3.1.3. Research Institutes
10.3.1.4. Cancer Centres
10.3.1.5. Others
10.4. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. GCC Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.2. GCC Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.3. GCC Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.4. South Africa Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.5. South Africa Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.6. South Africa Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.7. Egypt Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.8. Egypt Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.9. Egypt Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.10. Nigeria Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.11. Nigeria Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.12. Nigeria Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.13. Rest of Middle East & Africa Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.14. Rest of Middle East & Africa Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1.15. Rest of Middle East & Africa Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Artery Type vs Indication Heatmap
11.2. Manufacturer vs Indication Heatmap
11.3. Company Market Share Analysis, 2023
11.4. Competitive Dashboard
11.5. Company Profiles
11.5.1. Celsius42 GmbH
11.5.1.1. Company Overview
11.5.1.2. Product Portfolio
11.5.1.3. Financial Overview
11.5.1.4. Business Strategies and Development
11.5.2. Pyrexar Medical Inc.
11.5.2.1. Company Overview
11.5.2.2. Product Portfolio
11.5.2.3. Financial Overview
11.5.2.4. Business Strategies and Development
11.5.3. Oncothermia
11.5.3.1. Company Overview
11.5.3.2. Product Portfolio
11.5.3.3. Financial Overview
11.5.3.4. Business Strategies and Development
11.5.4. Hydrosun GmbH
11.5.4.1. Company Overview
11.5.4.2. Product Portfolio
11.5.4.3. Financial Overview
11.5.4.4. Business Strategies and Development
11.5.5. Yamamoto Vinita Co., Ltd
11.5.5.1. Company Overview
11.5.5.2. Product Portfolio
11.5.5.3. Financial Overview
11.5.5.4. Business Strategies and Development
11.5.6. Andromedic Srl
11.5.6.1. Company Overview
11.5.6.2. Product Portfolio
11.5.6.3. Financial Overview
11.5.6.4. Business Strategies and Development
11.5.7. Haifu Medical Technology Co. Ltd
11.5.7.1. Company Overview
11.5.7.2. Product Portfolio
11.5.7.3. Financial Overview
11.5.7.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Celsius42+ GmbH
  • Pyrexar Medical Inc.
  • Oncothermia
  • Hydrosun GmbH
  • Yamamoto Vinita Co., Ltd
  • Andromedic Srl
  • Haifu Medical Technology Co. Ltd

Methodology

Loading
LOADING...